#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary alveolar haemorrhage Restless legs syndrome Craniopharyngioma Small cell lung cancer Hepatic angiosarcoma Anaplastic thyroid cancer Non-small cell lung cancer Angelman's syndrome Friedreich's ataxia Dermatitis Haemophagocytic lymphohistiocytosis Giant cell tumour of tendon sheath Raynaud's phenomenon Anti-glomerular basement membrane disease Acute lymphocytic leukaemia recurrent More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III – Diagnostics Congenital nephrogenic diabetes insipidus – Treatment Arterial tortuosity syndrome – Diagnostics Wolfram syndrome Primary immunodeficiency syndrome – Treatment Undifferentiated sarcoma Synovial sarcoma recurrent – Trials in Disease Leiomyosarcoma Castleman’s disease – Diagnostics Brain stem glioma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bilastine Tropicamide ANTIMETABOLITES Dexpanthenol Cariprazine Hydrochloride Ab-729 Netupitant Clobetasol Propionate Miglustat AZD0120 Ursodoxicoltaurine Oxogluric Acid Landiolol Hydrochloride Olanzapine TAZAROTENE Rbd4059 Paliperidone Lovotibeglogene Autotemcel Albumin Mercaptopurine More therapies…

    Learn about Your Condition

    Pulmonary hypertension Endocrine ophthalmopathy Varices oesophageal Frostbite Osteoporosis postmenopausal Oesophageal cancer metastatic Neoplasm malignant Type V hyperlipidaemia Pseudomyxoma peritonei Haemofiltration Prader-Willi syndrome Pancreatitis acute Nasopharyngeal cancer Obesity Neck pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ovarian cancer

  • Study on Niraparib, Carboplatin, and Paclitaxel for Advanced Ovarian Cancer Patients After Tumor Removal

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer stage III
    • Fallopian tube cancer stage IV
    • Ovarian cancer stage IV
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Carboplatin
    • Paclitaxel
    Austria Belgium Czechia Germany Italy Spain

  • Study on Olaparib and Durvalumab for Patients with Advanced Ovarian Cancer Undergoing Surgery

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Durvalumab
    • Olaparib
    Germany

  • Study of Tulmimetostat (CPI-0209) for Patients with Advanced Solid Tumors and Lymphomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mesothelioma malignant
    • Lymphoma
    • Endometrial cancer
    Investigated Drugs:
    • Tulmimetostat
    • Enzalutamide
    France Italy Poland Spain

  • Study of PC14586 for Patients with Advanced Solid Tumors with a Specific TP53 Mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Endometrial cancer
    • Ovarian cancer
    Investigated Drugs:
    • Pc14586
    France Germany Italy Spain

  • Study Comparing Avutometinib and Defactinib with Other Treatments for Patients with Recurrent Low-Grade Serous Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Avutometinib
    • Defactinib
    • Doxorubicin Hydrochloride, Liposomal
    Belgium Denmark France Germany Ireland Italy +3

  • Study on the Effectiveness of Niraparib Rechallenge After Surgery in Ovarian Cancer Patients with Limited Metastasis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    Spain
Previous Page
1 … 4 5 6 7 8 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!